Lindeindia

India Listed Fortune MNC 500 · #258
Industrial gases and engineering services are offered by Linde across multiple sectors.
Request Access
Report Incorrect Data
Page last updated

About Lindeindia

Lindeindia is a publicly listed company based in India. Industrial gases and engineering services are offered by Linde across multiple sectors. It operates in the Healthcare and Chemicals & Materials sectors. The company has 259 employees. Its Indian entity Linde India Limited reported revenue of ₹2,604 Cr. Lindeindia offers products and services including Industrial Gases and Medical Gases. Its focus areas include Medical Supplies, Medical Gases, Oxygen Supply and Industrial Gases.

Company details

Linde is identified as a global supplier of industrial, specialty, and medical gases, with operations spanning over 80 countries. Its capabilities include providing gases and application technologies for industries such as chemicals, food, electronics, and healthcare, where productivity and sustainability are enhanced through innovations in emission control and process intensification. A comprehensive portfolio of services is delivered to support environmental goals and operational efficiency, ensuring reliable supply and engineering solutions are maintained across various applications.

Lindeindia is ranked #258 on the Fortune MNC 500 India (2026).

Recognitions & Rankings of Lindeindia

Fortune MNC 500 India 2026 edition
Rank#258
Total income
₹2,572 Cr
Profit
₹455 Cr
Last year #228
  • Headquarters India
  • Employees 259
  • Stage Public
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    ••••••••
  • Website lindeindia.in
  • Legal Name Linde India Limited
  • Date of Incorporation 24 Jan, 1935
  • Jurisdiction Kolkata, West Bengal, India
Operational Areas
Healthcare → Medical Equipment & Supplies
Chemicals & Materials → Industrial & Specialty Cleaning Solutions
Key Metrics
  • Market Cap
    ₹53,795 Cr

    LINDEINDIA · NSE

  • Share Price
    ₹6,859.00

    +8.73% today

  • Revenue
    ₹2,531 Cr

    FY 2025-26 · +1.8% YoY

  • EBITDA
    ₹909 Cr

    Margin 35.9%

  • Net Profit
    ₹548 Cr

    FY 2025-26 · +22.1% YoY

  • P/E (TTM)
    118.4x

    P/B 13.3x

  • ROE
    13.6%

    ROCE 17.8%

  • Debt / Equity
    0.01

    Interest cover 2.1x

  • Employee Count
    259

Products & Services of Lindeindia

Lindeindia offers a comprehensive portfolio of products and services, including Industrial Gases and Medical Gases.

Industrial Gases
Gases

Atmospheric gases such as oxygen, nitrogen, and argon are supplied for industrial applications, where productivity and sustainability are improved through various supply modes.

Medical Gases
Healthcare Supplies

Medical gases like oxygen and nitrous oxide are provided for healthcare settings, where safe delivery and comprehensive gas therapy solutions are ensured to support medical needs.

Board of directors of Linde India Limited (Lindeindia)

Linde India Limited is the primary company behind Lindeindia. The board of Linde India Limited currently have 6 directors; the longest-serving is Shalini Sarin, appointed in 2018. 28 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shalini Sarin
DIN 06604529
Director10 Jul 20188 yrs 3 moLinde India Limited
Mannu Sanganeria
DIN 09243027
Director29 Jul 20215 yrs 3 moLinde India Limited
Michael James Devine
DIN 10042702
Director15 Feb 20233 yrs 8 moLinde India Limited
Subba Rao Amarthaluru
DIN 00082313
Director23 Sep 20242 yrs 1 moLinde India Limited
Krishnan Sreenivasan Gobichettipalayam
DIN 00229417
Director23 Sep 20242 yrs 1 moLinde India Limited
Milan Sadhukhan
DIN 03082335
Additional Director01 Jan 202610 moLinde India Limited

IPO & Listings of Lindeindia

Lindeindia is a publicly listed company on the NSE with ticker symbol LINDEINDIA in India, operating in the Chemicals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: LINDEINDIA
  • Listed entityLinde India Limited
  • Exchange sectorChemicals

Financials of Lindeindia

Exchange-reported figures of Linde India Limited, the listed company behind Lindeindia (NSE: LINDEINDIA).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2,531 Cr
+1.8% YoY
EBITDA
₹909 Cr
+18.8% YoY
Profit After Tax
₹548 Cr
+22.1% YoY
Net Worth
₹4,267 Cr
+11.7% YoY
Total Assets
₹4,442 Cr
+11.8% YoY
Total Debt
₹78.92 Cr
+86.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Income statement
Revenue2,5312,4852,7693,1362,1121,4711,762
Revenue growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
EBITDA909765702765528375417
EBITDA margin+35.9%+30.8%+25.4%+24.4%+25.0%+25.5%+23.7%
Profit before tax7336145796186982291,013
Net profit548449430530308150122
Net profit margin+21.7%+18.1%+15.5%+16.9%+14.6%+10.2%+6.9%
EPS (₹)64.3753.3350.9050.4759.4717.7285.27
Balance sheet
Total assets4,4423,9743,6063,275---
Net worth4,2673,8203,4683,140---
Total debt78.9242.3720.6922.05---
Cash & bank1121479801,191---
Net working capital(165)(47.10)8971,116---
Cash flow
Cash from operations786584437629---
Cash from investing(705)(1,305)(539)(306)---
Cash from financing(116)(112)(105)(119)---
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue723694614701644571592606
Revenue growth (YoY)+12.3%+21.6%+3.8%+15.7%+1.5%-12.6%--
Other income10.737.466.5555.205.526.4613.4721.65
EBITDA232201173257282197210192
EBITDA margin+32.0%+28.9%+28.1%+36.6%+43.8%+34.5%+35.5%+31.7%
Depreciation67.4562.4160.7761.6856.4256.0055.5055.20
Interest15.815.942.665.543.153.156.551.61
Profit before tax159140116245228144161157
Tax40.2335.0838.5851.5157.2837.1442.8740.67
Net profit11910577.44193171107118116
EPS (₹)13.9312.269.0822.6720.0512.5713.8813.64
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Income statement
Revenue2,5312,4852,7693,1362,1121,4711,762
Revenue growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
EBITDA909765702765547375417
EBITDA margin+35.9%+30.8%+25.4%+24.4%+25.9%+25.5%+23.7%
Profit before tax7276065716147112361,013
Net profit550442422528302148122
Net profit margin+21.7%+17.8%+15.2%+16.8%+14.3%+10.1%+6.9%
EPS (₹)64.5952.5149.9950.2660.2618.2485.27
Balance sheet
Total assets4,4033,9333,5723,249---
Net worth4,2283,7793,4353,114---
Total debt78.9242.3720.6922.05---
Cash & bank1121479801,191---
Net working capital(165)(47.09)8971,116---
Cash flow
Cash from operations786584437629---
Cash from investing(705)(1,305)(539)(306)---
Cash from financing(116)(112)(105)(119)---
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue723694614701644571592606
Revenue growth (YoY)+12.3%+21.6%+3.8%+15.7%+1.5%-12.6%--
Other income6.875.905.9353.463.534.3412.9619.32
Total expenses492494441444362374382414
EBITDA232201173257282197210192
EBITDA margin+32.0%+28.9%+28.1%+36.6%+43.8%+34.5%+35.5%+31.7%
Depreciation67.4562.4160.7761.6856.4256.0055.5055.20
Interest15.815.942.665.543.153.156.551.61
Profit before tax155138115243226142161155
Tax40.2335.0830.2151.5157.2837.1442.8740.67

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 08 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue723694614701644571592606
Revenue growth (YoY)+12.3%+21.6%+3.8%+15.7%+1.5%-12.6%--
Other income10.737.466.5555.205.526.4613.4721.65
EBITDA232201173257282197210192
EBITDA margin+32.0%+28.9%+28.1%+36.6%+43.8%+34.5%+35.5%+31.7%
Depreciation67.4562.4160.7761.6856.4256.0055.5055.20
Interest15.815.942.665.543.153.156.551.61
Profit before tax159140116245228144161157
Tax40.2335.0838.5851.5157.2837.1442.8740.67
Net profit11910577.44193171107118116
EPS (₹)13.9312.269.0822.6720.0512.5713.8813.64
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Revenue2,5312,4852,7693,1362,1121,4711,762
Revenue growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
Other income73.7374.8784.7611335536.05860
Total expenses1,6221,7202,0662,3711,5841,0961,345
Employee cost56.8753.8753.8163.8750.2568.78114
EBITDA909765702765528375417
EBITDA margin+35.9%+30.8%+25.4%+24.4%+25.0%+25.5%+23.7%
Depreciation235214201253181176177
Interest14.5012.637.276.293.056.2486.25
Profit before tax7336145796186982291,013
Tax18515914580.2319177.56286
Net profit548449430530308150122
Net profit margin+21.7%+18.1%+15.5%+16.9%+14.6%+10.2%+6.9%
EPS (₹)64.3753.3350.9050.4759.4717.7285.27
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Equity & liabilities
Share capital85.2885.2885.2885.28---
Reserves & surplus4,1813,7353,3833,055---
Shareholders' funds (net worth)4,2673,8203,4683,140---
Minority interest0.000.000.000.00---
Secured loans0.000.000.000.00---
Unsecured loans78.9242.3720.6922.05---
Total debt78.9242.3720.6922.05---
Total liabilities4,4423,9743,6063,275---
Assets
Gross block3,9803,5813,2733,020---
Net block2,0931,9251,8221,762---
Capital work in progress1,343975483225---
Investments82.0274.4850.1632.05---
Inventories12310785.0477.41---
Sundry debtors508385481401---
Cash & bank balances1121479801,191---
Loans & advances308339381379---
Total current assets1,0529771,9272,049---
Total current liabilities1,2161,0241,030933---
Net working capital(165)(47.10)8971,116---
Total assets4,4423,9743,6063,275---
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Opening cash1459791,187983---
Net cash from operating activities786584437629---
Net cash from investing activities(705)(1,305)(539)(306)---
Net cash from financing activities(116)(112)(105)(119)---
Net change in cash(34.93)(833)(208)203---
Closing cash1121479801,191---
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Growth
Sales growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
EBITDA growth+18.8%+8.9%-8.2%-+40.8%-10.1%-
PBT growth+19.6%+6.0%+17.0%-29.1%+205.2%-77.4%+2472.8%
Net income growth+22.1%+4.6%-19.0%-+105.2%+22.8%-
Revenue CAGR (3Y)-6.9%+5.1%+21.5%+19.4%-1.2%-10.2%-1.2%
EBITDA CAGR (3Y)+5.9%+12.1%+21.3%+20.5%+17.4%+5.2%+13.3%
Profitability & leverage
Net income margin+21.7%+18.3%+15.7%+17.2%+24.0%+10.3%+41.3%
Return on capital employed+17.8%+16.5%+17.0%+16.3%+16.4%+10.0%+10.0%
Return on net worth+13.6%+12.5%+13.1%+14.7%+12.4%+6.9%+6.7%
Debt / equity0.010.010.010.010.010.030.36
Long-term debt / equity0.010.010.010.010.010.000.11
Interest cover2.152.291.451.230.883.1436.00
Efficiency & per share
Fixed asset turnover0.670.730.880.850.730.530.65
Inventory turnover22.0425.9334.0934.2430.6821.9625.84
Debtors turnover5.675.746.286.085.093.724.71
EPS (₹)64.3753.3350.9050.4759.4717.7285.27
Dividend per share (₹)12.0012.0012.0012.0013.503.0010.00
Book value per share (₹)500.28447.91406.69368.19318.33261.98254.67
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue723694614701644571592606
Revenue growth (YoY)+12.3%+21.6%+3.8%+15.7%+1.5%-12.6%--
Other income6.875.905.9353.463.534.3412.9619.32
Total expenses492494441444362374382414
EBITDA232201173257282197210192
EBITDA margin+32.0%+28.9%+28.1%+36.6%+43.8%+34.5%+35.5%+31.7%
Depreciation67.4562.4160.7761.6856.4256.0055.5055.20
Interest15.815.942.665.543.153.156.551.61
Profit before tax155138115243226142161155
Tax40.2335.0830.2151.5157.2837.1442.8740.67
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Revenue2,5312,4852,7693,1362,1121,4711,762
Revenue growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
Other income67.2667.8477.0110934943.79860
Total expenses1,6221,7202,0662,3711,5651,0961,345
Employee cost56.8753.8753.8163.8750.2568.78114
EBITDA909765702765547375417
EBITDA margin+35.9%+30.8%+25.4%+24.4%+25.9%+25.5%+23.7%
Depreciation235214201253181176177
Interest14.5012.637.276.293.056.2486.25
Profit before tax7276065716147112361,013
Tax17615914578.6519780.85286
Net profit550442422528302148122
Net profit margin+21.7%+17.8%+15.2%+16.8%+14.3%+10.1%+6.9%
EPS (₹)64.5952.5149.9950.2660.2618.2485.27
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Equity & liabilities
Share capital85.2885.2885.2885.28---
Reserves & surplus4,1423,6943,3493,029---
Shareholders' funds (net worth)4,2283,7793,4353,114---
Secured loans0.000.000.000.00---
Unsecured loans78.9242.3720.6922.05---
Total debt78.9242.3720.6922.05---
Total liabilities4,4033,9333,5723,249---
Assets
Gross block3,9803,5813,2733,020---
Net block2,0931,9251,8221,762---
Capital work in progress1,343975483225---
Investments43.0041.9226.5316.17---
Inventories12310785.0477.41---
Sundry debtors508385481401---
Cash & bank balances1121479801,191---
Loans & advances308339381379---
Total current assets1,0529771,9272,049---
Total current liabilities1,2161,0241,030933---
Net working capital(165)(47.09)8971,116---
Total assets4,4033,9333,5723,249---
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Opening cash1459791,187983---
Net cash from operating activities786584437629---
Net cash from investing activities(705)(1,305)(539)(306)---
Net cash from financing activities(116)(112)(105)(119)---
Net change in cash(34.93)(833)(208)203---
Closing cash1121479801,191---
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23Dec 2021Dec 2020Dec 2019
Growth
Sales growth+1.8%-10.2%-11.7%-+43.6%-16.5%-
EBITDA growth+18.8%+8.9%-8.2%-+45.8%-10.1%-
PBT growth+19.9%+6.2%+16.2%-30.9%+200.9%-76.7%+2047.8%
Net income growth+24.5%+4.8%-20.1%-+103.7%+21.4%-
Revenue CAGR (3Y)-6.9%+5.1%+21.5%+19.4%-1.2%-10.2%-1.4%
EBITDA CAGR (3Y)+5.9%+10.9%+21.3%+20.5%+18.8%+5.2%+12.0%
Profitability & leverage
Net income margin+21.8%+18.0%+15.4%+17.1%+24.3%+10.6%+41.3%
Return on capital employed+17.8%+16.5%+17.0%+16.3%+16.4%+10.4%+10.1%
Return on net worth+13.8%+12.4%+13.0%+14.8%+12.3%+7.2%+6.9%
Debt / equity0.020.010.010.010.010.030.37
Long-term debt / equity0.010.010.010.010.010.000.12
Interest cover2.152.291.451.230.843.1436.00
Efficiency & per share
Fixed asset turnover0.670.730.880.850.730.530.65
Inventory turnover22.0425.9334.0934.2430.6821.9625.84
Debtors turnover5.675.746.286.085.093.724.71
EPS (₹)64.5952.5149.9950.2660.2618.2485.27
Dividend per share (₹)12.0012.0012.0012.0013.503.0010.00
Book value per share (₹)495.70443.11402.72365.13315.54258.40250.56
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lindeindia

SC Orders Linde India To Provide SEBI With Valuation Report For Praxair Deal
Exchange Update • 2 days ago
LINDEINDIA: Q2 REVENUE 7.23B RUPEES VS 6.44B (YOY)
Exchange Update • 5 days ago
LINDEINDIA: Q2 CONS NET PROFIT 1.19B RUPEES VS 1.71B (YOY)
Exchange Update • 5 days ago
LINDEINDIA: Q2 EBITDA 2.35B RUPEES VS 2.82B (YOY); Q2 EBITDA MARGIN 32.55% VS 43.83% (YOY)
Exchange Update • 5 days ago
Linde India: Co Expands Semiconductor Footprint, Secures Sanand Land For New Chip-packaging Gas Facility - Newspaper
Exchange Update • 1 month ago
Linde Dominates AI Chip Contracts Amidst Undervalued Stock, While Air Products Outperforms Despite Losses
Wall St. • 1 month ago
Linde India consolidated net profit declines 2.43% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 2 months ago
Linde India Shares Fall 2.46% to Rs 6,800.50
Moneycontrol • 2 months ago
Linde India Q1 profit slips 2% despite 22% revenue growth as margins shrink - CNBC TV18
CNBCTV18 • 2 months ago
Linde India Appoints Vikash Dokania As CFO
Reuters • 2 months ago
Premium access

Complete news archive for Lindeindia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lindeindia

Lindeindia is headquartered in India.

Lindeindia has 259 employees.

The primary company behind Lindeindia, Linde India Limited, reported revenue of ₹2,604 Cr for FY 2026, up 2% year on year.

Linde is identified as a global supplier of industrial, specialty, and medical gases, with operations spanning over 80 countries. Its capabilities include providing gases and application technologies for industries such as chemicals, food, electronics, and healthcare, where productivity and sustainability are enhanced through innovations in emission control and process intensification. A comprehensive portfolio of services is delivered to support environmental goals and operational efficiency, ensuring reliable supply and engineering solutions are maintained across various applications.

Lindeindia offers Industrial Gases and Medical Gases.

Yes, Lindeindia is publicly traded on NSE under the ticker symbol LINDEINDIA.

Lindeindia operates through Linde India Limited.

The legal entities of Lindeindia currently have 8 directors, including Mannu Sanganeria, Shalini Sarin, Amit Dhanuka and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available